Copyright
©2008 The WJG Press and Baishideng.
World J Gastroenterol. Sep 28, 2008; 14(36): 5512-5518
Published online Sep 28, 2008. doi: 10.3748/wjg.14.5512
Published online Sep 28, 2008. doi: 10.3748/wjg.14.5512
Parameter | |
Age at diagnosis | A1 ≤ 16 yr |
A2 17-40 yr | |
A3 ≥ 40 yr | |
Maximal location of disease prior to first surgery | L1 Terminal ileal |
L2 Colonic | |
L3 Ileocolonic | |
L4 Upper GI only | |
+L4 Additional designation to be added if patient has upper GI and distal disease | |
Disease behavior | B1 Nonstricturing, nonpenetrating (inflammatory) |
B2 Stricturing | |
B3 Penetrating disease | |
P = Perianal penetrating disease | |
Recommended behavior assessed > 5 yr after diagnosis |
- Citation: Etchevers MJ, Aceituno M, Sans M. Are we giving azathioprine too late? The case for early immunomodulation in inflammatory bowel disease. World J Gastroenterol 2008; 14(36): 5512-5518
- URL: https://www.wjgnet.com/1007-9327/full/v14/i36/5512.htm
- DOI: https://dx.doi.org/10.3748/wjg.14.5512